A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: safety, reactogenicity and immunogenicity
View ORCID ProfileSonia Pérez-Rodríguez, Meiby de la Caridad Rodríguez-González, View ORCID ProfileRolando Ochoa-Azze, View ORCID ProfileYanet Climent-Ruiz, View ORCID ProfileCarlos Alberto González-Delgado, Beatriz Paredes-Moreno, View ORCID ProfileCarmen Valenzuela-Silva, View ORCID ProfileLaura Rodríguez-Noda, View ORCID ProfileRocmira Perez-Nicado, View ORCID ProfileRaúl González-Mugica, View ORCID ProfileMarisel Martínez-Pérez, View ORCID ProfileBelinda Sánchez-Ramírez, View ORCID ProfileTays Hernández-García, View ORCID ProfileAlina Díaz-Machado, View ORCID ProfileMaura Tamayo-Rodríguez, View ORCID ProfileAlis Martín-Trujillo, View ORCID ProfileJorman Rubino-Moreno, View ORCID ProfileAnamary Suárez-Batista, View ORCID ProfileMarta Dubed-Echevarría, View ORCID ProfileMaría Teresa Pérez-Guevara, View ORCID ProfileMayté Amoroto-Roig, View ORCID ProfileYanet Chappi-Estévez, View ORCID ProfileGretchen Bergado-Báez, View ORCID ProfileFranciscary Pi-Estopiñán, Guang-Wu Chen, View ORCID ProfileYuri Valdés-Balbín, View ORCID ProfileDagmar García-Rivera, View ORCID ProfileVicente Vérez-Bencomo
doi: https://doi.org/10.1101/2021.10.04.21264522
Sonia Pérez-Rodríguez
1National Centre of Toxicology (CENATOX), Havana, Cuba
Meiby de la Caridad Rodríguez-González
2Finlay Vaccine Institute, Havana, Cuba
Rolando Ochoa-Azze
2Finlay Vaccine Institute, Havana, Cuba
Yanet Climent-Ruiz
2Finlay Vaccine Institute, Havana, Cuba
Carlos Alberto González-Delgado
1National Centre of Toxicology (CENATOX), Havana, Cuba
Beatriz Paredes-Moreno
2Finlay Vaccine Institute, Havana, Cuba
Carmen Valenzuela-Silva
3Institute of Cybernetics, Mathematics and Physics, Havana, Cuba
Laura Rodríguez-Noda
2Finlay Vaccine Institute, Havana, Cuba
Rocmira Perez-Nicado
2Finlay Vaccine Institute, Havana, Cuba
Raúl González-Mugica
2Finlay Vaccine Institute, Havana, Cuba
Marisel Martínez-Pérez
2Finlay Vaccine Institute, Havana, Cuba
Belinda Sánchez-Ramírez
4Centre of Molecular Immunology, Havana, Cuba
Tays Hernández-García
4Centre of Molecular Immunology, Havana, Cuba
Alina Díaz-Machado
1National Centre of Toxicology (CENATOX), Havana, Cuba
Maura Tamayo-Rodríguez
1National Centre of Toxicology (CENATOX), Havana, Cuba
Alis Martín-Trujillo
1National Centre of Toxicology (CENATOX), Havana, Cuba
Jorman Rubino-Moreno
1National Centre of Toxicology (CENATOX), Havana, Cuba
Anamary Suárez-Batista
5Research Center of Civil Defense, Havana, Cuba
Marta Dubed-Echevarría
5Research Center of Civil Defense, Havana, Cuba
María Teresa Pérez-Guevara
5Research Center of Civil Defense, Havana, Cuba
Mayté Amoroto-Roig
6National Coordinating Centre of Clinical Trials
Yanet Chappi-Estévez
6National Coordinating Centre of Clinical Trials
Gretchen Bergado-Báez
4Centre of Molecular Immunology, Havana, Cuba
Franciscary Pi-Estopiñán
4Centre of Molecular Immunology, Havana, Cuba
Guang-Wu Chen
7Chengdu Olisynn Biotech. Co. Ltd., and State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, People’s Republic of China
Yuri Valdés-Balbín
1National Centre of Toxicology (CENATOX), Havana, Cuba
Dagmar García-Rivera
1National Centre of Toxicology (CENATOX), Havana, Cuba
Vicente Vérez-Bencomo
1National Centre of Toxicology (CENATOX), Havana, Cuba
Article usage
Posted October 05, 2021.
A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: safety, reactogenicity and immunogenicity
Sonia Pérez-Rodríguez, Meiby de la Caridad Rodríguez-González, Rolando Ochoa-Azze, Yanet Climent-Ruiz, Carlos Alberto González-Delgado, Beatriz Paredes-Moreno, Carmen Valenzuela-Silva, Laura Rodríguez-Noda, Rocmira Perez-Nicado, Raúl González-Mugica, Marisel Martínez-Pérez, Belinda Sánchez-Ramírez, Tays Hernández-García, Alina Díaz-Machado, Maura Tamayo-Rodríguez, Alis Martín-Trujillo, Jorman Rubino-Moreno, Anamary Suárez-Batista, Marta Dubed-Echevarría, María Teresa Pérez-Guevara, Mayté Amoroto-Roig, Yanet Chappi-Estévez, Gretchen Bergado-Báez, Franciscary Pi-Estopiñán, Guang-Wu Chen, Yuri Valdés-Balbín, Dagmar García-Rivera, Vicente Vérez-Bencomo
medRxiv 2021.10.04.21264522; doi: https://doi.org/10.1101/2021.10.04.21264522
A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: safety, reactogenicity and immunogenicity
Sonia Pérez-Rodríguez, Meiby de la Caridad Rodríguez-González, Rolando Ochoa-Azze, Yanet Climent-Ruiz, Carlos Alberto González-Delgado, Beatriz Paredes-Moreno, Carmen Valenzuela-Silva, Laura Rodríguez-Noda, Rocmira Perez-Nicado, Raúl González-Mugica, Marisel Martínez-Pérez, Belinda Sánchez-Ramírez, Tays Hernández-García, Alina Díaz-Machado, Maura Tamayo-Rodríguez, Alis Martín-Trujillo, Jorman Rubino-Moreno, Anamary Suárez-Batista, Marta Dubed-Echevarría, María Teresa Pérez-Guevara, Mayté Amoroto-Roig, Yanet Chappi-Estévez, Gretchen Bergado-Báez, Franciscary Pi-Estopiñán, Guang-Wu Chen, Yuri Valdés-Balbín, Dagmar García-Rivera, Vicente Vérez-Bencomo
medRxiv 2021.10.04.21264522; doi: https://doi.org/10.1101/2021.10.04.21264522
Subject Area
Subject Areas
- Addiction Medicine (430)
- Allergy and Immunology (755)
- Anesthesia (221)
- Cardiovascular Medicine (3288)
- Dermatology (277)
- Emergency Medicine (479)
- Epidemiology (13360)
- Forensic Medicine (19)
- Gastroenterology (898)
- Genetic and Genomic Medicine (5147)
- Geriatric Medicine (481)
- Health Economics (782)
- Health Informatics (3264)
- Health Policy (1140)
- Hematology (429)
- HIV/AIDS (1017)
- Medical Education (476)
- Medical Ethics (127)
- Nephrology (522)
- Neurology (4919)
- Nursing (262)
- Nutrition (727)
- Oncology (2519)
- Ophthalmology (723)
- Orthopedics (280)
- Otolaryngology (347)
- Pain Medicine (323)
- Palliative Medicine (90)
- Pathology (543)
- Pediatrics (1299)
- Primary Care Research (556)
- Public and Global Health (7500)
- Radiology and Imaging (1704)
- Respiratory Medicine (980)
- Rheumatology (479)
- Sports Medicine (424)
- Surgery (547)
- Toxicology (72)
- Transplantation (236)
- Urology (205)